This inventor holds 2 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Soochow University, Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 419 
1 out of 1 Years Active: 2025-2026
Title: The Innovations of Tao Xu in Biomedicine
Introduction
Tao Xu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly through his innovative work on PD-L1 binding polypeptides. His research focuses on the detection and diagnosis of PD-L1 related diseases, including various forms of cancer.
Latest Patents
Tao Xu holds 1 patent for his invention titled "PD-L1-binding polypeptide and use thereof." This invention is crucial in advancing the understanding and treatment of PD-L1 related diseases, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Throughout his career, Tao Xu has worked with notable companies such as Suzhou Smartnuclide Biopharmaceutical Co., Ltd. and Suzhou Pharmavan Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, furthering the development of biopharmaceuticals.
Collaborations
Tao Xu has collaborated with talented individuals in his field, including Yan Sun and Hao Qi. These partnerships have enriched his research and contributed to the advancement of biomedicine.
Conclusion
Tao Xu's work exemplifies the impact of innovation in the field of biomedicine. His contributions, particularly in the area of PD-L1 binding polypeptides, highlight the importance of research in combating serious health issues such as cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile